Overall, the V175M loss-of-function mutation in the human PEMT gene confers susceptibility to NASH (Song et al., 2005), and this has been shown in both the Chinese (Zhou et al., 2010) and Japanese population (Dong et al., 2007). This evidence concerns the gene PEMT and metabolic dysfunction-associated steatohepatitis.